Focused Investors LLC lowered its stake in Cigna Group (NYSE:CI - Free Report) by 2.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 571,650 shares of the health services provider's stock after selling 15,800 shares during the quarter. Cigna Group makes up approximately 6.0% of Focused Investors LLC's investment portfolio, making the stock its 4th largest position. Focused Investors LLC owned 0.21% of Cigna Group worth $188,073,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Florida Financial Advisors LLC lifted its holdings in shares of Cigna Group by 10.7% in the first quarter. Florida Financial Advisors LLC now owns 1,018 shares of the health services provider's stock worth $335,000 after acquiring an additional 98 shares during the last quarter. Prudent Man Advisors LLC raised its holdings in Cigna Group by 2.2% in the 1st quarter. Prudent Man Advisors LLC now owns 2,548 shares of the health services provider's stock valued at $838,000 after buying an additional 55 shares during the last quarter. Marks Group Wealth Management Inc raised its holdings in Cigna Group by 23.3% in the 1st quarter. Marks Group Wealth Management Inc now owns 27,164 shares of the health services provider's stock valued at $8,937,000 after buying an additional 5,141 shares during the last quarter. CWM LLC raised its holdings in Cigna Group by 8.9% in the 1st quarter. CWM LLC now owns 75,028 shares of the health services provider's stock valued at $24,684,000 after buying an additional 6,127 shares during the last quarter. Finally, Oxbow Advisors LLC raised its holdings in Cigna Group by 2.4% in the 1st quarter. Oxbow Advisors LLC now owns 19,642 shares of the health services provider's stock valued at $6,462,000 after buying an additional 454 shares during the last quarter. Institutional investors own 86.99% of the company's stock.
Cigna Group Price Performance
CI stock traded down $3.34 during mid-day trading on Tuesday, reaching $299.72. 214,697 shares of the company traded hands, compared to its average volume of 1,811,849. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.72 and a quick ratio of 0.72. The company has a market capitalization of $80.07 billion, a P/E ratio of 16.63, a P/E/G ratio of 0.90 and a beta of 0.44. Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a fifty day moving average price of $316.42 and a 200-day moving average price of $311.00.
Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. During the same quarter in the previous year, the firm earned $6.47 EPS. The company's quarterly revenue was up 14.4% compared to the same quarter last year. As a group, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.
Cigna Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.02%. The ex-dividend date of this dividend was Tuesday, June 3rd. Cigna Group's payout ratio is 33.44%.
Analyst Upgrades and Downgrades
CI has been the subject of a number of recent analyst reports. Robert W. Baird decreased their target price on shares of Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. TD Cowen raised shares of Cigna Group to a "strong-buy" rating in a research report on Monday, June 23rd. Truist Financial increased their target price on shares of Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Cowen reissued a "buy" rating on shares of Cigna Group in a research report on Monday, May 5th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $371.00 target price on shares of Cigna Group in a research report on Thursday, June 26th. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $380.39.
Get Our Latest Stock Analysis on Cigna Group
About Cigna Group
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More

Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.